ABSTRACT: Abortion is common. Data on abortion rates are inexact but can be used to explore trends. Globally, the estimated rate in the period 2010-2014 was 35 abortions per 1000 women (aged 15-44 years), five points less than the rate of 40 for the period 1990-1994. Abortion laws vary around the world but are generally more restrictive in developing countries. Restrictive laws do not necessarily deter women from seeking abortion but often lead to unsafe practice with significant mortality and morbidity. While a legal framework for abortion is a prerequisite for availability, many laws, which are not evidence based, restrict availability and delay access. Abortion should be available in the interests of public health and any legal framework should be as permissive as possible in order to promote access. In the absence of legal access, harm reduction strategies are needed to reduce abortion-related mortality and morbidity. Abortion can be performed surgically (in the first trimester, by manual or electric vacuum aspiration) or with medication: both are safe and effective. Cervical priming facilitates surgery and reduces the risk of incomplete abortion. Diagnosis of incomplete abortion should be made on clinical grounds, not by ultrasound. Septic abortion is a common cause of maternal death almost always following unsafe abortion and thus largely preventable. While routine follow-up after abortion is unnecessary, all women should be offered a contraceptive method immediately after the abortion. This, together with improved education and other interventions, may succeed in reducing unintended pregnancy.
Introduction
Abortion is common; around one in four women will have an abortion at some time in their lives. In developing countries, abortion is often unsafe and a significant cause of maternal morbidity and mortality. Between 2003 and 2009, induced abortion was estimated to have been responsible for 193 000 or 7.9% [95% uncertainty interval (UI): 4.7-13.2%] of the global total of 2 44 3000 maternal deaths (Say et al., 2014) . Although a simple and safe procedure, abortion remains controversial. Its availability depends not on medical or public health need but on religious, moral and political beliefs.
Abortion is legal on broad grounds in most European countries. Women seeking abortion are not different from those seen daily by reproductive medicine specialists in their clinics, operating theatres and delivery suites. Healthcare providers working in reproductive medicine should be informed about abortion and abortion care, even if they do not provide it. This article summarizes key points on abortion, its prevalence, availability, methods and safety, on post-abortion care and on efforts at preventing unintended pregnancy.
Searches on abortion topics were performed in Medline, Popline, EMBASE, the Cochrane library and the Social Sciences Citation Index databases for relevant English language publications from 1970 to 2016. Summaries were discussed at the ESHRE Capri Workshop. statistically significant. Within the developing regions, the highest rates were found in the Caribbean (~60-65). Rates showed little or no change over the period in Africa, and they increased in Latin America and decreased in most of Asia. Rates decreased throughout Europe as a whole, from 52 (48-64) in 1990-1994 to 30 (27-38) in 2010-2014; in Western Europe, however, the rate increased by five points (1-11) between 1990-1994 and 2010-2014 (Table I) .
Currently, an estimated 25% of all pregnancies conceived end in induced abortion.
In contrast to earlier reports (Sedgh et al., 2012) , the most recent abortion estimates no longer distinguish between 'safe' and 'unsafe' abortions since several recent developments, such as increased use of both manual vacuum aspiration (VA) instead of sharp curettage and of medical abortion, including use of misoprostol by women themselves, have blurred the distinction (Ganatra et al., 2014) .
Abortion laws
Abortion laws are typically described as a continuum from 'highly restrictive' to 'mostly legal' based on the combination of different indications: to save the woman's life, preserve her physical health, preserve her mental health, for rape or incest, foetal impairment, economic or social reasons or no restrictions. In 2013, 99% of women lived in countries where abortion was permitted to save their lives while less than one-third of countries (30%) allowed abortion without restriction ( Fig. 1 ) (United Nations, 2014) .
Since the mid-1990s there has been progress towards liberalized access to abortion. Altogether 56 countries liberalized their laws while eight countries voted on more stringent restrictions. Profound disparities exist between developed and developing countries (Fig. 1) . Only a minority of developing countries permit access to abortion on request (16%) or for socio-economic reasons (20%), while a vast majority of developed countries grant access for both indications (71 and 82%, respectively). The least developed countries maintain the most restrictive laws; only 6% allow abortion for socio-economic reasons and 4% on request (United Nations, 2014).
The legal status of abortion has no connection with overall incidence rates. In 2010-2014, overall abortion rates were estimated at 37 (35-51) per 1000 women in countries with no legal grounds for abortion but were lower at 34 (29-46) per 1000 in countries where abortion is legal on request (Sedgh et al., 2016) . Restricting access to abortion does not necessarily deter women from seeking it but does largely determine abortion-related mortality and morbidity as many women resort to unsafe, clandestine procedures. In 2011, rates of unsafe abortion were four times higher in countries with restrictive policies as compared to countries with liberal policies (26.7/1000 women versus 6.1/1000 women) (United Nations, 2014). The direct impact of the legal status on abortion-related mortality was clearly visible in Romania where maternal mortality dropped by 50% in <1 year following the liberalization of abortion laws in 1990 (Stephenson et al., 1992 ). An analysis based on five countries (South Africa, Ethiopia, Colombia, Nepal and Cambodia) and Mexico City, all of which lifted some restrictions on abortion access in the last two decades, also supports declining abortion-related mortality and morbidity (Guttmacher Institute, 2012) .
Many countries allowing abortion on request or for socio-economic reasons still have a myriad of regulations regarding gestational limit, type of provider, medical procedure, counselling, parental consent and funding, which in practice restrict access to abortion. While broadly legal across the European Union with the exception of Poland, Ireland and Malta, the legal conditions surrounding access and procedures vary substantially from country to country, revealing the lack of evidence informing legislative decisions. In the USA, individual states have accelerated the adoption of abortion restrictions (57 restrictions were passed in the year 2015 alone). While claiming to increase women's safety, none of these laws are based on evidence. Conversely, false information, increased waiting periods and lack of reimbursement are all designed to increase women's burden, with the potential to increase maternal complications by delaying abortion care (Guttmacher Institute, 2015) .
Methods of inducing abortion
Medical abortion using mifepristone with misoprostol and surgical abortion provided by trained healthcare providers, are both highly effective (Ireland et al., 2015) . In most countries where abortion is legal most procedures are carried out in the first trimester.
Surgical abortion

First trimester
VA is the recommended method for first trimester surgical abortion because of its superior effectiveness and safety compared to sharp curettage (Royal College of Obstetricians and Gynaecologists, 2011; World Health Organization, 2012) . VA is safe and effective even before 7 weeks' gestation provided the aspirate is inspected for the gestational sac (Paul et al., 2002) .
Second trimester
Dilatation and evacuation (D&E) is the recommended and most common method of surgical abortion in the second trimester. Advanced cervical dilation is induced with osmotic dilators, misoprostol or mifepristone several hours and up to 2 days before removal of the foetus and placenta using strong, elongated extraction forceps. D&E is quick (10-15 min) and highly acceptable (Kelly et al., 2010) . Intact dilatation and extraction (D&X) is performed after very wide (median 5 cm) cervical dilation is achieved using osmotic dilators over 2 or more days. This is followed by an assisted partial breech delivery, decompression of the calvarium and delivery of the foetus otherwise intact. Hysterotomy and hysterectomy are outdated methods and should not be used unless a transcervical approach is possible.
Cervical priming
While cervical priming is an integral part of the process of second trimester abortion, it has not been recommended routinely for all first trimester abortions.
However, in a recent RCT, uterine re-evacuation was less often needed in women undergoing surgical abortion who were pre-treated with misoprostol than those pre-treated with a placebo (0.78 versus 2.26%, respectively) (Meirik et al., 2012) . It has been suggested that pharmacological preparation of the cervix should be recommended as a routine part of surgical abortion in all women (Templeton, 2012) . The priming duration may be reduced to 1 hour if misoprostol is administered sublingually (Sääv et al., 2015) . second trimesters (Kulier et al., 2011; Wildschut et al., 2011) . Misoprostol alone is less effective but can be used if mifepristone is not available.
Medical abortion
First trimester
A typical regimen for medical abortion at ≤63 days' gestation comprises 200 mg oral mifepristone followed 24-48 h later by 800 µg misoprostol vaginally, sublingually or buccally. The interval between mifepristone and misoprostol can be reduced below 24 h or extended beyond 48 h but there is a trend toward lower success with <8 h between medications (Wedisinghe and Elsandabesee, 2010) . The regimen may be extended to 70 days' gestation (Abbas et al., 2015) . In Europe, medical abortion protocols typically require that mifepristone be administered in a clinic and there are often restrictions on the places where misoprostol can be administered. When women are given a choice of clinic or home use of misoprostol, there are no differences in rates of efficacy or complications between groups. Women can safely and effectively self-administer mifepristone (Swica et al., 2013) and misoprostol (Ngo et al., 2011) .
Second trimester
The regimen for which there is the most evidence is 200 mg oral mifepristone followed 36-48 h later by misoprostol every 3 h until delivery. Foeticide with intra-cardiac potassium chloride or intra-amniotic or intrafoetal digoxin is commonly used in the peri-viable period to avoid signs of life at delivery. In most settings, medical abortion after 9-10 weeks' gestation involves admission to a clinical facility.
Pain management
Options for pain management with surgical abortion include cervical anaesthesia and oral analgesia, conscious sedation and general anaesthesia particularly at higher gestation. For medical abortion, oral non-steroidal antiinflammatory drugs (NSAIDs) are the mainstay for pain relief (Jackson and Kapp, 2011) . Opioids may be given orally if NSAIDs are insufficient, particularly in the second trimester. A RCT demonstrated no benefit of giving ibuprofen prophylaxis 1 h before administration of misoprostol (Raymond et al. 2013 ).
Abortion complications
Abortion using modern methods has been extensively studied and in all settings is safer than continuing an unwanted pregnancy (Bruce et al., 2008) . Complications following both surgical and medical abortion are infrequent but national data on complication rates are not routinely collected, even in countries with robust registries. The rate of complications increases with the gestation at which abortion is induced (Grimes et al., 1984 , Zane et al., 2015 .
Immediate complications
The commonest immediate complications are ongoing pregnancy, incomplete abortion and infection.
Ongoing pregnancy and incomplete abortion
While ongoing pregnancy must be confirmed by ultrasound examination, incomplete abortion (retained products of conception (RPOC)) is a diagnosis that should be made on clinical grounds. Common symptoms include heavy or prolonged vaginal bleeding and abdominal pain.
Approximately 2-5% of women treated with the combination of mifepristone and misoprostol will require surgical intervention to resolve an incomplete abortion, terminate a continuing pregnancy or control bleeding (World Health Organisation Task Force on Postovulatory Methods for Fertility Regulation, 2000) . Continuing pregnancy occurs in some 0.9% of medical abortions performed with mifepristone/misoprostol and 0.2-00.5% of abortions with VA (Bygdeman and Danielsson 2002; Ireland et al., 2015) . Ultrasound examination after induced abortion almost always shows the presence of tissue in the uterine cavity regardless of symptoms of RPOC. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention (Reeves et al., 2009) . Inexperienced clinicians tend to intervene on the basis of the ultrasound findings regardless of symptoms (Gomperts et al., 2012) . Thus routine followup for all women after medical abortion leads to unnecessary intervention. The risk of incomplete abortion following medical abortion can be reduced by not offering routine follow-up particularly with ultrasound and by maintaining an interval of ≥24 h between mifepristone and misoprostol administration. Surgical abortion carries a smaller risk of incomplete evacuation (1%) (Niinimäki et al., 2009) . The risk of incomplete abortion following surgical abortion can be reduced by cervical priming.
Management
The decision about management of incomplete abortion by using either VA or misoprostol should be based upon the clinical condition of the woman and on her preference (World Health Organization, 2012) . Compared with sharp curettage, VA is associated with less blood loss, less pain and shorter procedure times. Sharp curettage after incomplete abortion is associated with a risk of subsequent intrauterine adhesions (Asherman syndrome); the approach is outdated and should not be used to treat incomplete abortion (Conforti et al., 2013) . The UK Royal College of Obstetricians and Gynaecologists recommends antibiotic prophylaxis, with either doxycycline or azithromycin, given before surgical evacuation for incomplete abortion, even if there is no suspicion of infection (Royal College of Obstetricians and Gynaecologists, 2015) .
Medical management of incomplete abortion uses misoprostol (600 µg oral or 400 µg sublingual). The presence of bleeding may decrease absorption when the drug is administered vaginally; thus, a non-vaginal route is generally preferable. Rates of complete abortion or of adverse events do not differ between VA or misoprostol for women with uterine size up to 13 weeks' gestation (Bique et al., 2007) 
Infection
The rate of infection after abortion is unclear since the definition is often vague. In a systematic review of complications of first trimester surgical abortions White et al. (2015) reported less than 2.0% of women returning for outpatient treatment for infection. In centres providing universal prophylaxis, or only treating women who were positive for Chlamydia, infection post-abortion occurred in <0.4% of cases. An overall frequency of post-abortion infection of <1% (range 0-6.1%) was reported for medical abortion (Shannon et al., 2004) . Infections, including septic abortion following unsafe abortions, are a significant cause of maternal morbidity and mortality. Infection is much more likely to occur, and much more likely to be severe, if the abortion has been performed unsafely. Clinical features suggestive of infection include, fever >37.5°C; localized or general abdominal tenderness, guarding and rebound; foul odor or pus visible in the cervical os and uterine tenderness. Hypotension, tachycardia and tachypnoea indicate the need for urgent intervention (Royal College of Obstetricians and Gynaecologists, 2015) .
In Europe, septic abortion is rare and almost always the consequence of an unsafe procedure. Treatment for septic abortion requires prompt and accurate recognition of infection, urgent removal of the infected products of conception, as well as the administration of fluid and broadspectrum antibiotics (Eschenbach, 2015) . If the skills necessary for urgent surgical uterine evacuation are not available, misoprostol can be used (Royal College of Obstetricians and Gynaecologists, 2015) .
Harm reduction strategies to protect women's health
The most effective way to reduce immediate abortion complications, including infections, is to follow medical guidelines delineating safe procedures. In the absence of legal grounds for abortion, harm reduction strategies (Hyman et al., 2013) promoting evidence-based use of misoprostol are shown to substantially decrease maternal morbidity and mortality. For example, in Uruguay (and elsewhere in Latin America) physicians give women accurate information about how to use misprostol to induce an abortion and offer a follow-up appointment in case of problems, but they do not prescribe misprosptol and nor do they tell women where to get it (Ganatra and Faundes, 2016) .
Medical guidelines to prevent abortionrelated infection
Before surgical abortion
Antibiotic prophylaxis at the time of abortion significantly reduces the likelihood of infection after VA (Sawaya et al., 1996) . A RCT showed that prophylaxis was more effective and less expensive than a screenand-treat approach for Chlamydia, gonorrhoea and bacterial vaginosis (Penney et al., 1998) . Doxycycline is widely used, and the evidence provides support for a single dose for 24 h of coverage, although some clinicians prefer presumptive treatment of Chlamydia with doxycycline (usually at a dose of 200 mg daily for 7 days); a single 1 g dose of azithromycin can be used instead, but is more expensive. In the UK, metronidazole is administered in addition to doxycycline or azithromycin at the time of either medical or surgical abortion, but there are no data to provide support for this routine practice (Templeton and Grimes, 2011) .
Before medical abortion
Data from RCTs of antibiotic prophylaxis with medical abortion are lacking. However, a large before-and-after study of US clinics providing medical abortion showed a marked decline (93%) in the rate of serious infections after implementation of routine antibiotic prophylaxis and a change in the route of misoprostol administration from vaginal to buccal (Fjerstad et al., 2009) . It is increasingly common in the UK for antibiotic prophylaxis to be used at the time of abortion, whether medical or surgical. Either a screen-and-treat or routine prophylaxis protocol should be in place (Royal College of Obstetricians and Gynaecologists, 2011).
Long-term sequelae
Few long-term sequelae are evident after abortion, and the morbidity and mortality are lower with induced abortion (either medical or surgical) than with pregnancy carried to term (Bruce et al., 2008) . Induced abortion has not been associated with an increased subsequent risk of ectopic pregnancy, infertility, placenta praevia or miscarriage (Royal College of Obstetricians and Gynaecologists, 2011). There are no data to suggest that medical abortion differs from surgical abortion. An association between induced abortion and a subsequent risk of preterm birth, which increases with the number of abortions, has been reported (Templeton and Grimes, 2011) . However, a recent review of 36 studies suggests there may be a difference between medical and surgical abortion in this respect. The authors conclude that the data 'warrant caution in the use of surgical evacuation and should encourage safer surgical techniques as well as medical methods' (Saccone et al., 2016) .
Two further putative risks warrant mention, particularly as they are a source of concern to those who are opposed to abortion. One is that abortion might be associated with an increased risk of breast cancer. The association, based on case-control studies, was refuted by more methodologically robust cohort studies including two large cohort studies (Reeves et al., 2006; Michels et al., 2007) , which showed no increased risk of breast cancer among women who had undergone one or more abortions, regardless of the woman's age, gestational age at abortion or the number of abortions.
The second putative risk is the effect of abortion on mental health. Numerous confounding factors predispose women to an unintended pregnancy and these same factors may also predispose them to poor mental health conditions (Charles et al., 2008) . However, most reviews/meta-analyses in recent years show no, or limited, increased short-or long-term risks of mental health problems following abortions (Charles et al., 2008; Major et al., 2009 ; Royal College of Psychiatrists. National Collaborating Centre for Mental Health, 2011). A robust study based on Danish population registers (Munk-Olsen et al., 2011) found no increased risk of mental disorders identified at psychiatric treatment facilities following first-trimester abortions.
Furthermore, in a recent study (Foster et al., 2015) , women receiving an abortion had similar or lower levels of depression and anxiety than women denied abortion.
Negative abortion experiences may, at least partially, stem from prior mental health problems, and can alert clinicians to possible underlying psychiatric problems (van Ditzhuijzen et al., 2015) suggesting that mental health screening and/or interventions may be advisable in abortion-care settings (Steinberg and Rubin, 2014) .
Post-abortion care
Post-abortion care for women should include access to 24-h emergency care, immediate provision of the chosen method of contraception and clear verbal and written advice about signs and symptoms indicative of the need to seek medical attention. In the absence of access to safe abortion services, post-abortion care is the sole option to prevent maternal morbidity and mortality by treating complications related to unsafe procedures (Ganatra and Faundes, 2016) .
In all settings, depending on gestation, anti-D Ig should also be given to non-sensitized Rhesus-negative women. Given the high efficacy and safety of modern medical and surgical methods of abortion, a routine follow-up visit with a healthcare provider is no longer considered a necessary part of abortion care.
Anti-D
Most guidelines continue to recommend anti-D administration to all non-sensitized Rhesus-negative women (to prevent Rhesus alloimmunization in a subsequent pregnancy) within 72 h after surgical or medical abortion at all gestations (Royal College of Obstetricians and Gynaecologists, 2011; World Health Organization, 2012; Qureshi et al., 2014) . However, there is no good quality evidence to justify this routine practice with first trimester abortion when feto-maternal haemorrhage (FMH) may be negligible. National guidelines in Norway (Norwegian Gynaecological Association, 2015) suggest 'considering' anti-D prophylaxis for abortion before 9 weeks' gestation while recommending it after nine weeks. The recommendation persists because the Rhesus D antigen is well developed by 6 weeks' gestation and there remains theoretical concern that the FMH may still be sufficient to cause immune sensitization (Karanth et al., 2013) .
When to start contraception
A total of 90% of women ovulate in the first month after first trimester abortion and more than half have resumed sex by two weeks (World Health Organization, 2012; Sääv et al., 2012) . Effective contraception should be commenced immediately if women want to avoid another unintended pregnancy (Royal College of Obstetricians and Gynaecologists, 2011; World Health Organization 2012) . Women who choose to start the most effective long-acting reversible methods of contraception (LARC), i.e. implantable and intrauterine contraception (IUC), immediately after the abortion have a significantly reduced risk of a subsequent unintended pregnancy compared to women choosing other methods (Heikinheimo et al., 2008; Cameron et al., 2012) . IUC can be safely inserted at surgical abortion or following expulsion of the fetus at medical abortion and uptake of IUC is higher the sooner it is provided after medical (Sääv et al., 2012) and surgical abortion (Bednarek et al., 2011) . Insertion of a progestogen contraceptive implant (Nexplanon ® ) at the time of mifepristone administration does not reduce the efficacy of early medical abortion (Raymond et al., 2016 , Hognert et al., 2016 .
Follow-up models of care
Routine follow-up is not necessary after an uncomplicated surgical or medical abortion where products of conception have been visualized (World Health Organization, 2012; Royal College of Obstetricians and Gynaecologists, 2011) . If products of conception have not been visualised by the provider, then post-abortion care should also include an effective means of confirming the success of the abortion. Telephone or Internet follow-up from the provider, with self-performed urine pregnancy tests (at home), has been shown to be a feasible, effective means of confirming completion and is acceptable to women (Bracken et al., 2014; Cameron et al., 2015) . Self-assessment (with no contact from the provider) with a self-performed low-sensitivity urine pregnancy test (detection limit 1000 IU HCG) is not inferior to ultrasound (Oppegaard et al., 2015) . Future research is required to determine the optimal urine pregnancy test for self-assessment (high, low or multilevel sensitivity tests) and the cost-effectiveness of this model of care.
Interventions to reduce unintended pregnancy
A thorough review of interventions aiming to reduce unintended pregnancy is beyond the scope of this article but a review of abortion would be incomplete without some discussion of prevention. Acknowledging the significant adverse public health impact of teenage pregnancy, most interventions have focused on adolescents. In general there is more political will to tackle teenage pregnancy than unintended pregnancy among adult women. Moreover in some settings, such as schools, adolescents are a readily available 'captive audience'. Many programmes aiming to prevent unintended pregnancy do not assess outcomes in terms of pregnancy or abortion rates but rather use intermediate outcomes such as contraceptive use, delayed onset of sexual debut or self-reported abstinence.
Legal restrictions to abortion
As discussed above, banning abortion or increasing barriers to access does not systematically prevent abortion.
Abstinence programmes
Encouraging abstinence as a way of avoiding unintended pregnancy and abortion among adolescents was extremely popular in the USA until 2009. Abstinence-only programmes recommended that delaying sexual activity until marriage was the only way to prevent out-of-wedlock pregnancy. The programmes deliberately excluded information about contraception or safer-sex practices. In a review of programmes (Manlove et al., 2015) , only 5 out of 14 mainly abstinence-based programmes were found to be effective with respect to any outcome including delayed sexual debut and reduced frequency of sexual activity. Only one programme (in Chile) reduced pregnancies or births (Cabezón et al., 2005) . In an analysis of 2005 data from 48 US states publishing information on sex education laws or policies, Stanger-Hall and Hall (2011) showed that increasing emphasis on abstinence education actually correlated positively with teenage pregnancy and birth rates.
Educational interventions
Educating the population (men as well as women) about the risks of unprotected sex and the action needed to avoid unwanted pregnancy seems an attractive strategy. Education is, of course, much easier to provide in schools and colleges and educating adults is hard. In a Cochrane review of interventions for adolescents, educational interventions promoting contraception and safe sex did not delay sexual debut among adolescents compared with controls [relative risk (RR) = 0.95, 95% CI: 0.71-1.27] (Oringanje et al., 2016) . Although educational interventions did significantly increase self-reported condom use at last sex compared with controls who did not receive the intervention (RR = 1.18, 95% CI: 1.06-1.32), it was unclear whether educational interventions had any effect on unintended pregnancy as this was not reported by any of the studies.
Interventions to improve contraceptive uptake or use
There can be no doubt that use of contraception prevents unintended pregnancies. Contraception has been provided free of charge to everyone in the UK through the National Health Service since 1973 and successive governments have chosen to continue free provision in the belief that without it unintended pregnancy rates would soar. Publicly funded family planning programmes providing free contraception to low-income women (and men) in the USA has been estimated to prevent over 2 million unintended pregnancies annually (Frost et al., 2014) . Interestingly, the UK and USA still have among the highest abortion rates in the industrialized world.
In an exploration of the fall in adolescent pregnancy rates in the USA between 1995 and 2002, Santelli et al. (2007) reported that the decline was primarily attributable to improved contraceptive use rather than to changes in sexual debut or frequency. Among 18-and 19-year old, the decline was entirely attributable to increased contraceptive use while among 15-to 17-year old it was responsible for~77% of the decline. However, specific interventions designed to measurably reduce unintended pregnancy, even when there are promising data from observational studies or when an intervention seems intuitively sensible, have often proved disappointing. Shields, 2005, Hou et al., 2010) . A record linkage study undertaken in California, USA, showed that women who received a 1-year supply of oral contraceptive pills were less likely to have a pregnancy than women getting three cycles or just one cycle of pills. (Foster et al., 2011) The authors suggested that providing a 1-year supply of pills might avert unintended pregnancies but it remains to be seen whether such an intervention would prove effective if it were tested using the robust methodology of a RCT with pregnancy as outcome. In recent years, enthusiasm for LARC intrauterine contraceptives and implants (independent of compliance for its efficacy) has spawned several studies encouraging uptake as a means of preventing repeat abortion. In one case-note review of over 900 women, those choosing IUC following the abortion were 20 times less likely (and implant users 16 times less likely) to have a repeat abortion than women who chose an oral contraceptive pill (Cameron et al., 2012) . In a large study in St Louis, MI, USA, an intervention designed to increase uptake of IUC and contraceptive implants has resulted in significantly lower abortion rates and teenage pregnancy rates compared with a similar population in Kansas, USA (Peipert et al., 2012) . In countries where unmet need for contraception is high, contraceptive use, whatever the method, does much to reduce unintended pregnancy (Thomas and Karpilow, 2016) . In countries where contraception is freely available and widely used it is possible that increased uptake of the most effective contraceptives may reduce unintended pregnancy rates.
Multicomponent interventions
It is hard to change people's behaviour with a single intervention. Multiple interventions with many components and with pregnancy as an end-point are hard to test, particularly as randomized trials. There is, however, some persuasive evidence from public health interventions. In 1999, the UK Government launched a 10-year nationwide Teenage Pregnancy Strategy (TPS) in England, which aimed to reduce pregnancies by 50% among women aged >18 years (Wellings et al., 2016) . The intervention consisted of a national media campaign, improvements to young people's sexual and reproductive health services including contraceptive provision and improvements to sex education, support for young parents to increase participation in education, training or employment, and co-ordinated action between health and education services. Between 1998 and 2014, pregnancy rates fell by 51%. In an examination of the progress of the TPS, Wellings et al. (2016) concluded that, while a fall in teenage pregnancies had been seen in the last 20 years in many European countries, the fall in the UK was much greater. Thus a multifaceted policy intervention involving both health and education agencies was effective in significantly reducing pregnancy rates (ending in both childbirth and abortions) in the UK.
Conclusions
Abortion is a safe and effective procedure, which can be undertaken by providers with limited medical training, and, in the case of medical abortion, by women themselves. A choice of methods of inducing abortion exists and few clinical issues remain unresolved. The benefit of cervical priming before all surgical abortions now seems clear but cost-effectiveness needs to be determined. Whether there is a need for an infection prevention protocol before all abortion procedures, medical as well as surgical, and which protocol to use, will remain controversial as long as global concerns about increasing antibiotic resistance persist, but further study is warranted. The need to give anti-D Ig to Rhesus-negative women undergoing first trimester abortions needs to be clarified. Finally, the evidence on the effect of abortion on subsequent fertility, on breast cancer and on mental health is reassuring and it is safer to abort a pregnancy than to continue it to childbirth. Abortion will always exist. In societies in which the average woman is sexually active from ages 16 to 45 years and wishes a small family, a considerable number of years are spent trying to avoid pregnancy. Contraception is not perfect and the methods most commonly in use today worldwide have relatively high failure rates. Although increased use of LARC is likely to reduce unintended pregnancy rates at a population level, uptake will need to be rather high if it is to make a big impact (Marston and Cleland 2003) . Abortion should be made as accessible as possible as a public health measure as well as enabling women to have control over their own fertility. Banning abortion or making it difficult to obtain simply drives it underground, often leading to large numbers of deaths and disabilities. In the context of slow progress towards legal access to safe abortion services globally, harm reduction strategies are effectively used to reduce abortion-related mortality and morbidity.
